[1]
Bohan A, History and classification of polymyositis and dermatomyositis. Clinics in dermatology. 1988 Apr-Jun;
[PubMed PMID: 3293742]
[2]
Strauss KW,Gonzalez-Buritica H,Khamashta MA,Hughes GR, Polymyositis-dermatomyositis: a clinical review. Postgraduate medical journal. 1989 Jul;
[PubMed PMID: 2690042]
[3]
Dalakas MC, Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies. Nature clinical practice. Neurology. 2006 Aug;
[PubMed PMID: 16932602]
[4]
Kamiya M,Mizoguchi F,Takamura A,Kimura N,Kawahata K,Kohsaka H, A new in vitro model of polymyositis reveals CD8 T cell invasion into muscle cells and its cytotoxic role. Rheumatology (Oxford, England). 2020 Jan 1;
[PubMed PMID: 31257434]
[5]
Karpati G,Pouliot Y,Carpenter S, Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Annals of neurology. 1988 Jan
[PubMed PMID: 3278673]
[6]
Richardson SJ,Lopez F,Rojas S,Cho S,Holodniy M,Herndier B,Katz J, Multinodular polymyositis in a patient with human immunodeficiency and hepatitis C virus coinfection. Muscle & nerve. 2001 Mar
[PubMed PMID: 11353433]
[7]
Dalakas MC,Pezeshkpour GH,Gravell M,Sever JL, Polymyositis associated with AIDS retrovirus. JAMA. 1986 Nov 7;
[PubMed PMID: 3464769]
[8]
Gómez Rodríguez N,Ibáñez Ruán J,González Rodríguez M, [Coxsackie virus infection associated with myositis and polyarthritis]. Anales de medicina interna (Madrid, Spain : 1984). 2008 Feb
[PubMed PMID: 18432367]
[9]
Hill CL,Zhang Y,Sigurgeirsson B,Pukkala E,Mellemkjaer L,Airio A,Evans SR,Felson DT, Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet (London, England). 2001 Jan 13;
[PubMed PMID: 11197446]
[10]
Shapiro M,Blanco DA, Neurological Complications of Gastrointestinal Disease. Seminars in pediatric neurology. 2017 Feb;
[PubMed PMID: 28779865]
[11]
Grable-Esposito P,Katzberg HD,Greenberg SA,Srinivasan J,Katz J,Amato AA, Immune-mediated necrotizing myopathy associated with statins. Muscle
[PubMed PMID: 19813188]
[13]
Marie I,Hatron PY,Levesque H,Hachulla E,Hellot MF,Michon-Pasturel U,Courtois H,Devulder B, Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine. 1999 May;
[PubMed PMID: 10352646]
[14]
Liu T,Hou Y,Dai TJ,Yan CZ, Upregulation of Interleukin 21 and Interleukin 21 Receptor in Patients with Dermatomyositis and Polymyositis. Chinese medical journal. 2017 Sep 5;
[PubMed PMID: 28836555]
[15]
Allenbach Y,Chaara W,Rosenzwajg M,Six A,Prevel N,Mingozzi F,Wanschitz J,Musset L,Charuel JL,Eymard B,Salomon B,Duyckaerts C,Maisonobe T,Dubourg O,Herson S,Klatzmann D,Benveniste O, Th1 response and systemic treg deficiency in inclusion body myositis. PloS one. 2014;
[PubMed PMID: 24594700]
[16]
Moran EM,Mastaglia FL, The role of interleukin-17 in immune-mediated inflammatory myopathies and possible therapeutic implications. Neuromuscular disorders : NMD. 2014 Nov;
[PubMed PMID: 25052503]
[17]
Creus KK,De Paepe B,De Bleecker JL, Idiopathic inflammatory myopathies and the classical NF-kappaB complex: current insights and implications for therapy. Autoimmunity reviews. 2009 Jun;
[PubMed PMID: 19232550]
[18]
Schnabel A,Hellmich B,Gross WL, Interstitial lung disease in polymyositis and dermatomyositis. Current rheumatology reports. 2005 Apr;
[PubMed PMID: 15760588]
[19]
Kuo SH,Vullaganti M,Jimenez-Shahed J,Kwan JY, Camptocormia as a presentation of generalized inflammatory myopathy. Muscle
[PubMed PMID: 19750541]
[20]
Satoh M,Tanaka S,Ceribelli A,Calise SJ,Chan EK, A Comprehensive Overview on Myositis-Specific Antibodies: New and Old Biomarkers in Idiopathic Inflammatory Myopathy. Clinical reviews in allergy
[PubMed PMID: 26424665]
Level 3 (low-level) evidence
[22]
Chahin N,Engel AG, Correlation of muscle biopsy, clinical course, and outcome in PM and sporadic IBM. Neurology. 2008 Feb 5;
[PubMed PMID: 17881720]
[23]
Elessawy SS,Abdelsalam EM,Abdel Razek E,Tharwat S, Whole-body MRI for full assessment and characterization of diffuse inflammatory myopathy. Acta radiologica open. 2016 Sep;
[PubMed PMID: 27708860]
[24]
Shimojima Y,Ishii W,Matsuda M,Kishida D,Ikeda SI, Effective Use of Calcineurin Inhibitor in Combination Therapy for Interstitial Lung Disease in Patients With Dermatomyositis and Polymyositis. Journal of clinical rheumatology : practical reports on rheumatic
[PubMed PMID: 28225510]
[25]
Cherin P,Pelletier S,Teixeira A,Laforet P,Genereau T,Simon A,Maisonobe T,Eymard B,Herson S, Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients. Arthritis and rheumatism. 2002 Feb;
[PubMed PMID: 11840450]
[26]
Marie I,Menard JF,Hatron PY,Hachulla E,Mouthon L,Tiev K,Ducrotte P,Cherin P, Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients. Arthritis care
[PubMed PMID: 20722047]
[27]
Schiffenbauer A,Garg M,Castro C,Pokrovnichka A,Joe G,Shrader J,Cabalar IV,Faghihi-Kashani S,Harris-Love MO,Plotz PH,Miller FW,Gourley M, A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis. Seminars in arthritis and rheumatism. 2018 Jun;
[PubMed PMID: 29174792]
Level 1 (high-level) evidence
[28]
Ueno KI,Shimojima Y,Kishida D,Sekijima Y,Ikeda SI, Advantage of administering tacrolimus for improving prognosis of patients with polymyositis and dermatomyositis. International journal of rheumatic diseases. 2016 Dec;
[PubMed PMID: 27457756]
[29]
Alexanderson H, Exercise: an important component of treatment in the idiopathic inflammatory myopathies. Current rheumatology reports. 2005 Apr;
[PubMed PMID: 15760590]
[30]
Bronner IM,van der Meulen MF,de Visser M,Kalmijn S,van Venrooij WJ,Voskuyl AE,Dinant HJ,Linssen WH,Wokke JH,Hoogendijk JE, Long-term outcome in polymyositis and dermatomyositis. Annals of the rheumatic diseases. 2006 Nov;
[PubMed PMID: 16606652]
[31]
Rai SK,Choi HK,Sayre EC,Aviña-Zubieta JA, Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study. Rheumatology (Oxford, England). 2016 Mar;
[PubMed PMID: 26424835]
[32]
Chen YJ,Wu CY,Huang YL,Wang CB,Shen JL,Chang YT, Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan. Arthritis research
[PubMed PMID: 20398365]
[33]
Nicoletis I,Pasco J,Maillot F,Goupille P,Corcia P,Grammatico-Guillon L,Machet L, High pre-treatment neutrophil-to-lymphocyte ratio in patients with dermatomyositis/polymyositis predicts an increased risk of cancer. European journal of dermatology : EJD. 2020 Apr 10;
[PubMed PMID: 32281931]
[34]
de Merieux P,Verity MA,Clements PJ,Paulus HE, Esophageal abnormalities and dysphagia in polymyositis and dermatomyositis. Arthritis and rheumatism. 1983 Aug;
[PubMed PMID: 6882490]
[35]
Carruthers EC,Choi HK,Sayre EC,Aviña-Zubieta JA, Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study. Annals of the rheumatic diseases. 2016 Jan;
[PubMed PMID: 25193998]
[36]
Tseng CC,Chang SJ,Tsai WC,Ou TT,Wu CC,Sung WY,Hsieh MC,Yen JH, Increased Incidence of Amyotrophic Lateral Sclerosis in Polymyositis: A Nationwide Cohort Study. Arthritis care
[PubMed PMID: 27723283]
[37]
Lee CW,Muo CH,Liang JA,Sung FC,Hsu CY,Kao CH, Increased osteoporosis risk in dermatomyositis or polymyositis independent of the treatments: a population-based cohort study with propensity score. Endocrine. 2016 Apr;
[PubMed PMID: 26429781]
[38]
Lu X,Yang H,Shu X,Chen F,Zhang Y,Zhang S,Peng Q,Tian X,Wang G, Factors predicting malignancy in patients with polymyositis and dermatomyostis: a systematic review and meta-analysis. PloS one. 2014;
[PubMed PMID: 24713868]
Level 1 (high-level) evidence